Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis - Wikidata - wikimedia - TriplyDB

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q26853462

about

High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.What is the Prognostic Significance of Ki-67 Positivity in Oral Squamous Cell Carcinoma?CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis.Enhanced photoelectrochemical aptasensing platform for TXNDC5 gene based on exciton energy transfer between NCQDs and TiO2 nanorods.Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study.Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer BCL2 Regulation According to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database.Activin A regulates microRNAs and gene expression in LNCaP cells.The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway.Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies.The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients.Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes.Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer.Differential effect of psoralidin in enhancing apoptosis of colon cancer cells via nuclear factor-κB and B-cell lymphoma-2/B-cell lymphoma-2-associated X protein signaling pathways.FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes.Bcl-2 antigen expression in luminal A and triple-negative breast cancer.IDH1R132H Promotes Malignant Transformation of Benign Prostatic Epithelium by Dysregulating MicroRNAs: Involvement of IGF1R-AKT/STAT3 Signaling Pathway.Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy.The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer.

P2860

Q35552790-210C043D-1494-43C9-B332-331227533D53 Q36012992-248FE469-6274-4AC4-9070-84BD13F82143 Q36148171-B443463B-4E84-4944-8B80-0CE531C21F34 Q36499840-C9240CEC-33EA-4531-A085-A373D3AD428F Q37417691-2A96B351-0206-409E-B770-E2873061E884 Q37735963-AC2DF26A-B93F-4B34-BE34-CEC581A320CF Q38682221-03084ACA-D89E-4585-9947-DD2A12A79449 Q38782894-E27C250E-1A70-4ACD-9C10-EF605CDD4648 Q38929364-2822F17F-A5A8-44B3-B62E-71B9903E15A9 Q40772764-2DDE5A02-4482-4ACB-8C0A-5D6DE328418E Q41140848-B334D4A5-6D04-4508-96CE-2FA31CC4F483 Q41535142-B605E491-CDC0-4772-AAD5-453D95774853 Q41550079-159C375F-68D1-49B5-9A13-FFE73D43B58D Q41869081-B25DF223-ACC6-435B-B367-70CC40912EBF Q47547132-9EB21223-623A-44D5-BB90-7CCC76E4FA31 Q47961905-A4810FBA-2CCE-470D-B44E-225DCAD2E8AE Q49329227-A1CC7DF7-44C8-4974-B3E3-3BBFC0682659 Q51549809-623121F7-054C-4C31-B68B-A67B084344BC Q55356724-877F5F19-0E2C-42C7-9276-9BC0035546FD

P2860

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q26853462

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

@ast

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

@en

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

@nl

type

label

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

@ast

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

@en

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

@nl

prefLabel

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

@ast

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

@en

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

@nl

P1433

Q26853462-03BA750F-7D45-4721-9C27-36070B24074D

P1476

Q26853462-D392A3C4-566E-4CFC-BEF5-10F4D9731798

P2093

Q26853462-182ED457-3701-4832-B706-069B7C77353A

Q26853462-61507BFC-AFF8-46F1-87C0-0BCEE7C4BC95

Q26853462-79502CE5-DC84-4110-A727-229C8DDFA9E6

Q26853462-83662AA1-29FC-4356-9D5F-9F9DC99ECDB8

Q26853462-83C4FEC6-F7A5-41F3-8EB5-1FB8B43C99A6

Q26853462-95181542-C77E-45D4-9D62-BE715F4AE857

Q26853462-9E5744F7-13A1-4584-8F9B-010A4368EC55

Q26853462-A8E984C2-3C64-4365-BA4C-346FC3544B79

Q26853462-BE3C4C75-3DBA-42AF-BCAA-4F59E1630945

Q26853462-C4C3436C-C991-4E51-9D37-172DBBCBEC43

P304

Q26853462-7DFDC5CA-00D2-424F-9F70-881DBB6F98FA

P31

Q26853462-1760ED7C-28C3-4E2A-9BAE-94AF8E6C9FD4

Q26853462-1EF3BB71-D47B-444F-A027-1D7A22DE8D10

Q26853462-432951FE-D979-419C-8A01-A870DA0510EF

P3181

Q26853462-336A2227-8ED2-4BD7-9CF9-5D08687F985B

P356

Q26853462-F16E879C-1398-4B87-B08B-A226B05D2214

P407

Q26853462-093972CD-9398-4B8E-9EFC-FC7708E54908

P433

Q26853462-27A574B7-6AC1-4CA6-88FE-3A69C7B63740

P478

Q26853462-19740DCE-079C-499D-A766-854F0A1AE058

P577

Q26853462-0318453D-EED2-4C8F-AD01-8FD8967F2F28

P5875

Q26853462-5859862B-4965-497D-9428-AA51C324D461

P698

Q26853462-C91BE416-C183-45EC-8036-6ADE07F092D5

P921

Q26853462-8B9B10CC-0E25-4EEC-A684-362738DAD76C

Q26853462-F83F8F72-BB04-4D8E-971B-4162E4C80138

P3181

P356

1055-9965.EPI-13-0696

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Tissue biomarkers for prognosis of prostate cancer: a systematic review and meta-analysis

@en

P2093

J. Wang

http://www.w3.org/2001/XMLSchema#string

L. Zhao

http://www.w3.org/2001/XMLSchema#string

M. Liu

http://www.w3.org/2001/XMLSchema#string

N. Yu

http://www.w3.org/2001/XMLSchema#string

P. Hu

http://www.w3.org/2001/XMLSchema#string

T. Guo

http://www.w3.org/2001/XMLSchema#string

X. Tang

http://www.w3.org/2001/XMLSchema#string

X. Yang

http://www.w3.org/2001/XMLSchema#string

Y. Hou

http://www.w3.org/2001/XMLSchema#string

Z. Zeng

http://www.w3.org/2001/XMLSchema#string

P304

1047-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

3277535

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1055-9965.EPI-13-0696

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260873602

http://www.w3.org/2001/XMLSchema#string

P698

24636974

http://www.w3.org/2001/XMLSchema#string

P921